Analog Devices target raised at Jefferies to $51, Jefferies said. Improving order rates. Hold rating. BJ's Restaurants ( BJRI) numbers lowered at Oppenheimer. Shares of BJRI now seen reaching $38, Oppenheimer said. Estimates also lowered as model remains challenged. Outperform rating. Bruker ( BRKR) numbers raised at UBS. Shares of BRKR now seen reaching $21, UBS said. Estimates also increased on double digit organic growth and EPS beat in 4Q. Buy rating. Conagra ( CAG) estimates, target raised at Credit Suisse. Shares of CAG now seen reaching $36, according to Credit Suisse. Estimates also increased, as the company is carrying a lot of momentum into 2013. Neutral rating. Chemed Corporation ( CHE) target raised at Oppenheimer to $91, Oppenheimer said. Fourth quarter beat. Outperform rating. Express Scripts ( ESRX) numbers boosted at Lazard. Shares of ESRX now seen reaching $65, according to Lazard Capital Markets. Estimates also upped, given better operating trends. Buy rating. Express estimates, target boosted at Wedbush. Shares of EXPR now seen reaching $22, according to Wedbush. Estimates also upped, given positive early checks on the Spring season. Outperform rating. First Solar ( FSLR) numbers raised at UBS. Shares of FSLR now seen reaching $36, UBS said. Estimates also increased on expected guide up for 2013 on higher margins. Neutral rating. Medtronic ( MDT) estimates, target increased at BMO. MDT estimates were raised through 2015, BMO Capital said. Company continues to grow across the board. Outperform rating and new $52 price target. Omnicare ( OCR) estimates, target upped at JP Morgan. OCR estimates were boosted through 2014, JP Morgan said. Company raised its guidance. Overweight rating and new $45 price target. Qualcomm ( QCOM) added to Conviction Buy List at Nomura. QCOM was placed on the US Conviction Buy list, according to Nomura. Company is a market leader and should see improving traction in China. $75 price target. Realogy ( RLGY) estimates, target raised at JP Morgan. Shares of RLGY now seen reaching $51, according to JP Morgan. Estimates also increased, given better business trends. Overweight rating. Sealed Air ( SEE) numbers raised at Jefferies. Shares of SEE now seen reaching $25, Jefferies said. Estimates also raised on hard stance on pricing and restructuring underway. Buy rating.